Hamilton Thomas Edward — SEC insider filings
SEC reporting owner CIK 1769848. 19 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2020-09-30 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 6 filings — 651,378 shares, $2,850,181 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 80,000 shares, $734,432 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 317,460 shares @ $3.15 ($999,999) in Larimar Therapeutics, Inc., filed 2022-09-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | Director | 12 | 6 legs · 651,378 sh · $2,850,181 | — | 7 |
| ANNALY CAPITAL MANAGEMENT INC (NLY) | Director | 7 | — | 1 leg · 80,000 sh · $734,432 | 6 |
Insider filings — Hamilton Thomas Edward
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 70,000 @ $2.67 | EDGAR |
| 2026-07-08 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 50,000 @ $3.34 | EDGAR |
| 2026-06-12 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 8,641 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 100,000 @ $5 | EDGAR |
| 2025-05-15 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 8,961 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 57,208 @ $8.74 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 8,583 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 8,167 (derivative) @ $0 | EDGAR |
| 2023-05-11 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 8,300 (derivative) @ $0 | EDGAR |
| 2022-09-20 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 317,460 @ $3.15 | EDGAR |
| 2022-05-20 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 24,372 (derivative) @ $0 | EDGAR |
| 2022-05-12 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 8,300 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Larimar Therapeutics, Inc. (LRMR) | Purchase (P): 56,710 @ $8.75 | EDGAR |
| 2021-05-21 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Grant/award (A): 15,609 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 8,300 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | ANNALY CAPITAL MANAGEMENT INC (NLY) | Sale (S): 80,000 @ $9.18 | EDGAR |
| 2020-09-30 | 4 | Larimar Therapeutics, Inc. (LRMR) | Grant/award (A): 16,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769848 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs